HUMA
Humacyte, Inc. · Healthcare
President, CEO and Director Laura E Niklason sold $2.4M of Humacyte, Inc.
Sold$2,364,521
$5.30Price
446,378Shares
−8%Stake
What HUMA did after the filing
- The stock from Wed, Sep 11 close, $5.69
- +0.5%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Oct 23 close.
Traded Mon, Sep 9. Filed Wed, Sep 11, 1:50 PM ET, during the session. Returns use the Sep 11 close and the Oct 23 close. Not investment advice.